$0.77
+0.03(3.49%)
Mkt Cap $6M
$0.29
$1.73
52-Week Range
At a Glance
AI-generatedPasithea Therapeutics faced a year of deepening losses as it concentrated resources on advancing its core clinical programs, while strategic capital raises provided a strengthened liquidity position to fund ongoing operations and development.
8-K
Pasithea Therapeutics Corp. disclosed under Item 3.01 on February 20, 2026, a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This indicates potential non-compliance with exchange listing requirements.$6M
Market Cap
—
Revenue
-$13M
Net Income
Employees4
Fundamentals
How The Business Makes Money
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Industry Biotechnology
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001841330
ISINUS70261F2020
CUSIP70261F103
Phone702 514 4174
Address1111 Lincoln Road, Miami Beach, FL, 33139, US
SEC EDGAR